MONTOR-LC KID SYRUP

Oral Liquids

MONTOR-LC KID SYRUP

PACKING:
192 x 60 ml

COMPOSITION:

Each 5 ml contains:

Montelukast Sodium
I.P.
 
Equivalent to Montelukast
I.P.
4 mg
Levocetirizine Dihydrochloride
I.P.
2.5 mg
 
DESCRIPTION:
Montor-LC syrup is a combination of Montelukast Sodium and Levocetirizine. Montelukast Sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteine leukotriene (CysLT1), receptor. Levocetirizine is a third-generation non-sedative antihistamine, developed from the second-generation antihistamine Cetirizine. Chemically, Levocetirizine is the active enantiomer of Cetirizine.
 
MECHANISM OF ACTION:
Montelukast inhibits bronchoconstriction due to antigen challenge. Montelukast is a selective leukotriene receptor antagonist of the cysteinyl leukotriene CysLT1 receptor. The cysteinyl leukotrienes (LTC 4, LTD 4, and LTE 4) are products of arachidonic acid metabolism that are released from various cells, including mast cells and eosinophils. Levocetirizine works by blocking histamine receptors. It does not prevent the actual release of histamine from mast cells, but prevents binding it to its receptors. This in turn prevents the release of other allergy chemicals and increased blood supply to the area, and provides relief.
 
INDICATIONS:
Relief of symptoms of allergic rhinitis (seasonal or perennial), as prophylaxis in seasonal allergic rhinitis.
 
CONTRAINDICATIONS:
Contraindicated in patients with known hypersensitivity to Montelukast sodium, Levocetirizine or cetirizine or to any other component of this product.
 
SIDE EFFECTS:
Fatigue, dry mouth, dyspepsia, abdominal pain, dizziness, headache, cough, nasal congestion.
 
DOSAGE:
As directed by the physician.
 
STORAGE:
Store in a cool & dry place. Protect from light.
 
SHAKE WELL BEFORE USE
PRESENTATION:
60 ml bottle
 
0118906044107530, 0108906044107533
https://getinfoon.net/